Weller, Jonathan
Katzendobler, Sophie
Niedermeyer, Sebastian
Harter, Patrick N.
Herms, Jochen
Trumm, Christoph
Niyazi, Maximilian
Thon, Niklas
Tonn, Joerg-Christian
Stoecklein, Veit M.
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 10 May 2023
Accepted: 1 June 2023
First Online: 8 June 2023
Declarations
:
: Jonathan Weller - No disclosures. Sophie Katzendobler - No disclosures. Sebastian Niedermeyer - No disclosures. Patrick Harter - No disclosures. Jochen Herms - No disclosures. Maximilian Niyazi – MN has received honoraria for lectures or advisory board participation or consulting from Brainlab and Novocure. Niklas Thon - No disclosures. Joerg-Christian Tonn - Consultant/speaker honoraria from BrainLab and Carthera, and royalties from Springer Publisher Intl. Veit M Stoecklein - No disclosures.
: Ethics approval was obtained by the ethics committee of the Ludwig Maximilian University of Munich (project number 23–0052).
: in retrospective studies is given prospectively by all patients treated at the Department of Neurosurgery of the Ludwig Maximilian University of Munich through a local prospective tumor registry.
: All authors have consented in submitting this manuscript for publication in the Journal of Neuro-Oncology.